PerkinElmer and Mallinckrodt Help Bottom Ten Stocks in XLV
XLV's Best and Worst Performers in the Last Week of August
XLV’s bottom ten outperform top ten
Within the Health Care Select Sector SPDR ETF (XLV), the top ten stocks according to market cap underperformed the bottom ten stocks. The bottom ten stocks’ average return was 2.51% for the period between August 25 to August 31. The top ten stocks’ average return was 1.91% for the same period. The bottom ten stocks collectively outperformed the top ten stocks with consistent returns among all ten stocks except Patterson Companies (PDCO), which fell by 4.10%.
The above graph reflects the performance of XLV’s top ten versus the bottom ten for the period between August 25 to August 31.
PerkinElmer and Mallinckrodt outperform, while Patterson underperforms
PerkinElmer (PKI) with a return of 5.94% was the best performer of XLV’s bottom ten stocks. The company presented its expertise on its multi-modality imaging solutions at World Molecular Imaging Congress’s annual meeting on September 2 to September 5.
Mallinckrodt Pharmaceuticals (MNK) gained 5.22% on higher trade volumes, as it was in the oversold territory with a relative strength index (or RSI) of 33.
The top ten holdings were supported by Gilead Sciences (GILD) and UnitedHealth Group (UNH) with a return of 4.39% and 4.77%, respectively. GILD published the results from the study of first-line treatment with Letairis and Tadalafil in pulmonary arterial hypertension. The trials were conducted in collaboration with GlaxoSmithKline (GSK).
Browse this series on Market Realist: